CORONA Remedies Limited (NSE:CORONA)
India · Delayed Price · Currency is INR 1,750.60
+18.90 (1.09%)
At close: Jun 16, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 107.07 billion as of June 16, 2026.
Market Cap
107.07B
Enterprise Value
108.27B
Revenue
14.03B
Ranking
n/a
PE Ratio
57.83
Stock Price
1,750.60
Market Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 107.07B, an increase of 21.70%. That is a compound annual growth rate of 47.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 107.07B | 26.41% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 213.43B |
| AstraZeneca Pharma India | 206.10B |
| Granules India | 189.84B |
| Caplin Point Laboratories | 183.29B |
| Jubilant Pharmova | 154.48B |
| Viyash Scientific | 109.09B |
| Procter & Gamble Health | 104.14B |
| Sanofi India | 71.85B |